comparemela.com

Latest Breaking News On - Evgen pharma - Page 1 : comparemela.com

Theracryf : Annual Report and Accounts 2023-24

THERACRYF PLC ANNUAL REPORT & FINANCIAL STATEMENTS 2024 FOCUSSING ON ONCOLOGY AND NEUROPSYCHIATRY .

City ofUnited kingdomEvgen pharmaSusan clement daviesAllan youngBarry clareSusan fodenChronos therapeutics ltdKings college londonErasmus medical centreCentre for affective disordersInstitute of psychiatryClement daviesTherapeutics ltdProfessor allan youngMood disorders

Notice of Results | Company Announcement

Investegate announcements from Notice of Results

Alderley parkBorough of cheshire eastUnited kingdomCity ofMelanie toyne sewell jack kincadeHuw jonesNigel birks harrietEvgen pharmaSapienza universitHelen kuhlmanInvestor meet companyUniversity of connecticutKings college londonUniversity of manchesterLondon stock exchange regulatory news serviceInvestor meet

Chronos Integration Update | Company Announcement

Investegate announcements from Chronos Integration Update

United kingdomCity ofAlderley parkBorough of cheshire eastToni haenninenEvgen pharmaMelanie toyne sewell jack kincadeNigel birks harrietSapienza universitHuw jonesHelen kuhlmanKings college londonUniversity of manchesterChronos therapeuticsChronos therapeutics ltdUniversity of connecticut

Seneca Partners Reduces Stake in Theracryf PLC

Evgen Pharma (GB:TCF) has released an update. In a major shift of voting rights, Seneca Partners Limited has reported a decrease from 5.93% to 3.81.

Seneca partnersEvgen pharmaSeneca partners limitedReaking news

Evgen Pharma plc will Change its Ticker to TCF from EVG

Effective April 26, 2024, Evgen Pharma plc will change its London Stock Exchange AIM Market stock ticker symbol to TCF from EVG..

City ofUnited kingdomEvgen pharmaLondon stock exchangeEffective april

vimarsana © 2020. All Rights Reserved.